Prof Kausik K Ray (Imperial College London, UK) discusses results of the resutls of the Phase 3 ORION-11 trial - Impact of inclisiran on LDL-C over 18 months in patients with ASCVD or risk-equivalent.
Filmed on site at ESC 2019 by Radcliffe Cardiology.